Effect of Music Therapy on Pain

November 24, 2009 updated by: Association de Musicothérapie Applications et Recherches Cliniques

Effect of Music Therapy on Chronic Pain in Hospitalized Patients in a Pain Center

The aim of study is to assess the effects of this new music therapy technique on pain treatment, anxiety and depression and on medicinal consumption.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The "U" technique is a music therapy method of recent use developed by taking into account recommendations of the scientific literature. The objective of the study is to evaluate this method on chronic painful patients presenting a lumbago, a fibromyalgia, an inflammatory or neurological pathology. During the hospitalization, the intervention group benefited from at least 2 daily sessions of music therapy between day 0 and day 10, and continued the musicotherapy at home until day 60. The evaluated criteria are pain, depression and anxiety and their evolution after 60 days of treatment (since the inclusion). The evaluation at day 90 allows to test the persistence of the effect of the music therapy 90 days later.

Study Type

Interventional

Enrollment (Actual)

87

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Montpellier, France, 34295
        • CHRU Saint Eloi, Centre d'Evaluation et du Traitement de la Douleur

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Have a pain for more than 6 months
  • Pain of neurological origin (fibromyalgia, algodystrophies), or skeletal musculous (back, sciatic nerve)
  • Speak and read French fluently
  • Wrote consent of patients
  • Benefit from the standard treatment : Intravenous treatment (tranquillizer, antidepressive) the first 5 days, 2 time by day (in the morning and evening), followed by the intermediary orally up to the exit (prescribed doses and at request)

Exclusion Criteria:

  • Time of hospitalization < 8 days
  • Reflex epilepsy history
  • Major insufficiency of auditory function
  • Patient with a strong possibility of not compliance to the protocol or of abandon in the course of study
  • Presence of an illness threatening vital forecast during period envisaged for the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Music therapy
Individual receptive music therapy by "U sequence" method
Other: Individual receptive music therapy by "U sequence" method
During the hospitalization, the intervention group benefited from at least 2 daily sessions of music therapy between day 0 and day 10, and continued the musicotherapy at home until day 60.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Score on a Visual Analogical Scale (VAS) for actual pain
Time Frame: Day 0, day 5, day 10, day 60 and day 90
Day 0, day 5, day 10, day 60 and day 90

Secondary Outcome Measures

Outcome Measure
Time Frame
Score on the Hospital Anxiety and Depression (HAD) Scale
Time Frame: Day 0, day 5, day 10, day 60 and day 90
Day 0, day 5, day 10, day 60 and day 90
Medicinal consumption
Time Frame: Before hospitalization, day 0, day 5, day 10, day 60 and day 90
Before hospitalization, day 0, day 5, day 10, day 60 and day 90

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Association de Musicothérapie Applications et Recherches Cliniques

Collaborators

Centre d'Evaluation et du Traitement de la Douleur CHU Saint-Eloi
Unité de Recherche Clinique et Epidémiologie (DIM) CHU Arnaud de Villeneuve
Centre Mémoire de Ressource et de Recherche équipe INSERM U888 CHU Montpellier

Investigators

  • Principal Investigator: Stéphane GUETIN, PhD, Association de Musicothérapie Applications et Recherches Cliniques

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2006

Primary Completion (ACTUAL)

November 1, 2008

Study Completion (ACTUAL)

December 1, 2008

Study Registration Dates

First Submitted

November 23, 2009

First Submitted That Met QC Criteria

November 24, 2009

First Posted (ESTIMATE)

November 25, 2009

Study Record Updates

Last Update Posted (ESTIMATE)

November 25, 2009

Last Update Submitted That Met QC Criteria

November 24, 2009

Last Verified

November 1, 2009

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • AMARC 200801

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Pain

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Latvia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe